Articles by Erin Slifka

The Covid-19 vaccine being developed by the University of Oxford and AstraZeneca was found to be as much as 90% effective in preventing infections without serious side effects in a large clinical trial.

After scrambling to hoard cash in the spring, some large U.S. companies that halted their dividend payments are reversing their decision, a sign that their leaders believe the worst of the crisis is behind them.

Nevada Gov. Steve Sisolak restricted public gathering in Las Vegas casinos and other areas of life in response to rising Covid-19 cases, as the state struggles to balance health concerns with its hospitality-focused economy.

The Covid-19 pandemic is changing an entrenched aspect of car shopping in America: finding your new ride on the lot and driving it home that day.

Startups around the country are finding Bay Area workers more open than ever to living and working outside tech’s largest hubs.

The president-elect’s transition team sharply criticized Treasury Secretary Steven Mnuchin’s decision to allow funding for several emergency Federal Reserve lending programs to expire, escalating a political fight.

Regeneron’s Covid-19 antibody drug is the second cleared this month to treat patients who aren’t hospitalized but are at high risk of developing severe disease.